StemCell Therapy

April 20, 2012 18:19 PM

IBN Discovers Human Neural Stem Cells, Promising Discovery For Breast Cancer Therapy

By Tengku Noor Shamsiah Tengku Abdullah

SINGAPORE, April 20 (Bernama) -- Could engineered human stem cells hold the key to cancer survival?

Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have discovered that neural stem cells possess the innate ability to target tumor cells outside the central nervous system.

This finding, which was demonstrated successfully on breast cancer cells, was recently published in leading peer reviewed journal, Stem Cells.

Despite decades of cancer research, cancer remains a leading cause of death worldwide, accounting for 7.6 million deaths in 2008, and breast cancer is one of the most common causes of cancer deaths each year.

In Singapore, more than 1,400 women are diagnosed with breast cancer and more than 300 die as a result of breast cancer annually.

A team of researchers led by IBN group leader Dr Shu Wang, has made a landmark discovery that neural stem cells (NSCs) derived from human induced pluripotent stem (iPS) cells could be used to treat breast cancer.

The effectiveness of using NSCs, which originate from the central nervous system, to treat brain tumors has been investigated in previous studies.

View original post here:
IBN Discovers Human Neural Stem Cells, Promising Discovery For Breast Cancer Therapy

This entry was posted on April 22, 2012 at 12:10 am and is filed under Death by Stem Cells. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |